# Attenua

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/attenua

- Industry: Pharmaceuticals
- Headquarters: San Mateo, US
- Website: www.attenua.com
- Total disclosed funding: $15M
- Latest round: Series A (Apr 17, 2018)
- Investors on record: 4

## About

Attenua Inc. specializes in domain name sales, offering a premium domain name, AttenUa.com, aimed at enhancing online branding for businesses and individuals.Founded in 2015 and headquartered in San Mateo, US, Attenua Inc. operates primarily in the digital domain sales sector. The company has undergone a strategic pivot towards domain acquisition and resale. In February 2020, Attenua Inc. was acquired by CODA Biotherapeutics, Inc., a portfolio company of Astellas Venture Management, MPM Capital, Novartis, and Versant Ventures. The financial terms of this acquisition were not disclosed. The company has successfully completed a Series A funding round, raising a total of USD 15.20 mn, led by Omega Funds, and supported by investors including Abingworth, OrbiMed Advisors, and Redmile Group.AttenUa.com is positioned as a premium domain name available for purchase, which is the company's primary product offering. The domain is marketed for USD 795 or can be acquired through a payment plan of USD 33.13 per month over 24 months. This service facilitates immediate use upon purchase, enabling clients to establish their online presence quickly. The target customers include entrepreneurs, businesses, and individuals seeking to enhance their brand identity through a memorable web address. The products are offered to clients worldwide, highlighting the global nature of digital business and online branding.The revenue model for AttenUa.com is based on direct sales of domain names, primarily through transactions on their website. Customers can complete purchases immediately or choose a structured payment plan, creating a steady income stream for the company. The pricing structure is straightforward, with the flagship product priced at USD 795, ensuring clarity for potential buyers. This approach generates revenue through both immediate sales and ongoing monthly payments from customers who opt for installment plans.Looking ahead, Attenua Inc. plans to leverage its recent funding from the Series A round to further develop its product offerings and enhance market penetration. The company aims to continue exploring new digital products that complement its domain sales by 2023. Additionally, it seeks to expand its market reach into new geographical regions, focusing particularly on emerging markets in Asia and Europe. Recent investment will support these initiatives, although specific details regarding new product releases or geographic targets have not yet been disclosed.

## Funding rounds

- Series A, Apr 17, 2018, $15M — Abingworth, OrbiMed Advisors, Omega Funds, Redmile Group

## Investors

- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series A
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series A